Drug-introduced photo-crosslinked hyaluronic acid derived gel

Details for Australian Patent Application No. 2006266741 (hide)

Owner Seikagaku Corporation

Inventors Yasuda, Yousuke; Miyamoto, Kenji

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006266741

PCT Pub. Number WO2007/004675

Priority 2005-198176 06.07.05 JP

Filing date 5 July 2006

Wipo publication date 11 January 2007

Acceptance publication date 1 September 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 31/192 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/004675 Priority application(s): WO2007/004675

7 April 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Drug-introduced photo-crosslinked hyaluronic acid derived gel

1 September 2011 Application Accepted

  Published as AU-B-2006266741

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006266751-Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions

2006266731-Oscillatory wave detecting apparatus